Yu Kintai

Yu Kintai is a prominent scientist and researcher affiliated with Fudan University and Huashan Hospital in Shanghai, China. He leads a team that has made significant breakthroughs in understanding Parkinson's disease, particularly in identifying a novel therapeutic target, the FAM171A2 protein. His team's research, which spans over five years, has revealed critical insights into the mechanisms of pathological alpha-synuclein propagation in neurons, offering potential new avenues for treatment that could delay disease progression and improve the quality of life for millions of patients. This research has gained international attention and was recently published in a leading scientific journal.